What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?

作者: R Magnard , Y Vachez , C Carcenac , P Krack , O David

DOI: 10.1038/TP.2016.17

关键词: NeurosciencePramipexoleBehavioral medicineDementiaClinical psychologyApathyPsychologySchizophreniaDiseaseAnhedoniaParkinson's disease

摘要: In addition to classical motor symptoms, Parkinson's disease (PD) patients display incapacitating neuropsychiatric manifestations, such as apathy, anhedonia, depression and anxiety. These hitherto generally neglected non-motor have gained increasing interest in medical scientific communities over the last decade because of extent their negative impact on PD patients' quality life. Although recent clinical functional imaging studies provided useful information, pathophysiology apathy associated affective impairments remains elusive. Our aim this review is summarize discuss advances development rodent models PD-related symptoms using neurotoxin lesion-based approaches. The data collected suggest that bilateral partial lesions nigrostriatal system aimed at inducing reliable neuropsychiatric-like deficits while avoiding severe may interfere with behavioral evaluation, a more selective efficient strategy than medial forebrain bundle lesions. Moreover, all different classes pharmacological agents, D2/D3 receptor agonists pramipexole appear be most treatment for wide range induced by dopaminergic Lesion-based models, therefore, relevant tools studying PD. Data accumulated so far confirm causative role depletion, especially system, related They also put forward receptors potential targets

参考文章(139)
Richard G. Brown, Graham Pluck, Negative symptoms: the ‘pathology’ of motivation and goal-directed behaviour Trends in Neurosciences. ,vol. 23, pp. 412- 417 ,(2000) , 10.1016/S0166-2236(00)01626-X
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A.I de Vos, Ernst N.H Jansen Steur, Eva Braak, Staging of brain pathology related to sporadic Parkinson’s disease Neurobiology of Aging. ,vol. 24, pp. 197- 211 ,(2003) , 10.1016/S0197-4580(02)00065-9
Masayuki Matsumoto, Okihide Hikosaka, Ethan S. Bromberg-Martin, Dopamine in Motivational Control: Rewarding, Aversive, and Alerting Neuron. ,vol. 68, pp. 815- 834 ,(2010) , 10.1016/J.NEURON.2010.11.022
Tao Sun, Wei He, Gang Hu, Ming Li, Anxiolytic-like property of risperidone and olanzapine as examined in multiple measures of fear in rats Pharmacology Biochemistry and Behavior. ,vol. 95, pp. 298- 307 ,(2010) , 10.1016/J.PBB.2010.02.005
Kimberly McDowell, Marie-Françoise Chesselet, Animal models of the non-motor features of Parkinson's disease Neurobiology of Disease. ,vol. 46, pp. 597- 606 ,(2012) , 10.1016/J.NBD.2011.12.040
C.A. Brown, M.C. Campbell, M. Karimi, S.D. Tabbal, S.K. Loftin, L.L. Tian, S.M. Moerlein, J.S. Perlmutter, Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys Experimental Neurology. ,vol. 236, pp. 190- 197 ,(2012) , 10.1016/J.EXPNEUROL.2012.04.025
V. Gradinaru, M. Mogri, K. R. Thompson, J. M. Henderson, K. Deisseroth, Optical Deconstruction of Parkinsonian Neural Circuitry Science. ,vol. 324, pp. 354- 359 ,(2009) , 10.1126/SCIENCE.1167093
Naomi P. Visanji, Jordi Gomez-Ramirez, Tom H. Johnston, Donna Pires, Valerie Voon, Jonathan M. Brotchie, Susan H. Fox, Pharmacological characterization of psychosis‐like behavior in the MPTP‐lesioned nonhuman primate model of Parkinson's disease Movement Disorders. ,vol. 21, pp. 1879- 1891 ,(2006) , 10.1002/MDS.21073